Network pharmacology and molecular docking reveal the mechanism of Angelica dahurica against Osteosarcoma.
Zhang Y, Li Z, Wei J, Kong L, Song M, Zhang Y, Xiao X, Cao H, Jin Y.
Medicine (Baltimore). 2022 Nov 4;101(44):e31055. doi: 10.1097/MD.0000000000031055.
RUNX2 and Osteosarcoma.
Li N, Luo D, Hu X, Luo W, Lei G, Wang Q, Zhu T, Gu J, Lu Y, Zheng Q.
Anticancer Agents Med Chem. 2015;15(7):881-7. doi: 10.2174/1871520615666150304151228.
Fracture of an os peroneum.
Fabbro ME, Bigness AR, Taylor JA.
J Can Chiropr Assoc. 2020 Aug;64(2):155-157.
Immunotherapy for osteosarcoma.
Yahiro K, Matsumoto Y.
Hum Vaccin Immunother. 2021 May 4;17(5):1294-1295. doi: 10.1080/21645515.2020.1824499. Epub 2020 Dec 24.
Optimal management of symptomatic os acromiale: current perspectives.
Spiegl UJ, Millett PJ, Josten C, Hepp P.
Orthop Res Rev. 2018 Feb 14;10:1-7. doi: 10.2147/ORR.S141480. eCollection 2018.
The roles of glycolysis in osteosarcoma.
Feng Z, Ou Y, Hao L.
Front Pharmacol. 2022 Aug 17;13:950886. doi: 10.3389/fphar.2022.950886. eCollection 2022.
Os Trigonum Syndrome: A Cause of Posterior Ankle Pain.
Ulrich GL, Meyers AL, Marquart MJ.
Orthopedics. 2024 Mar-Apr;47(2):e67-e72. doi: 10.3928/01477447-20240122-04. Epub 2024 Jan 25.
Exosomes and osteosarcoma drug resistance.
Fu H, Wu Y, Chen J, Hu X, Wang X, Xu G.
Front Oncol. 2023 Mar 17;13:1133726. doi: 10.3389/fonc.2023.1133726. eCollection 2023.
Role of osteopontin in osteosarcoma.
Li YS, Deng ZH, Zeng C, Lei GH.
Med Oncol. 2015 Jan;32(1):449. doi: 10.1007/s12032-014-0449-y. Epub 2014 Dec 17.
Tumor-associated macrophages in osteosarcoma.
Zhao Y, Zhang B, Zhang Q, Ma X, Feng H.
J Zhejiang Univ Sci B. 2021 Nov 15;22(11):885-892. doi: 10.1631/jzus.B2100029.
